Bavarian Nordic Announces Appointment of Jean-Christophe May as Executive Vice President and Chief Commercial Officer

    NEXT STORY
    Oncology Venture advancing towards next milestone in its clinical development of IXEMPRA®.
    PREV STORY
    Innate Pharma third quarter 2019 report
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Medical Oxygen Systems Market to Cover US$ 4 Bn by 2024 end – Persistence Market Research

    Global Sales of Medical Oxygen Systems will Procure Nearly US$ 4 Billion by 2024-endNew ...

    author_avatar
    NASDAQ Market News

    Radius Health Announces Five Presentations on elacestrant (RAD1901) at the San Antonio Breast Cancer Symposium (SABCS)

    SABCS to include five abstracts from the development program for elacestrant as a potential ...

    author_avatar
    NASDAQ Market News

    CRISPR Therapeutics to Participate in May Investor Conferences

    ZUG, Switzerland and CAMBRIDGE, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused ...

    author_avatar
    NASDAQ Market News